Stay updated on Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now includes a dedicated Locations section listing study sites by state (California, Florida, Illinois, Massachusetts, Missouri, New York, North Carolina, Ohio, Pennsylvania, Virginia, Wisconsin) and the revision metadata was updated to v3.3.3, replacing the previous state-specific location headings.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedPublications section text now clarifies that publications are automatically filled from PubMed and may not all relate to the study. The revision label has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check48 days agoChange DetectedThe funding/operating status banner was removed from the page. The core study details and eligibility information remain unchanged.SummaryDifference0.4%

- Check69 days agoChange DetectedThe new screenshot shows a redesigned layout and header; study details, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check91 days agoChange DetectedThe page has been updated to include a government-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference4%

- Check98 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

Stay in the know with updates to Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.